TAIMED BIOLOGICS
TaiMed Biologics Inc. operates as a biotechnology company. The company develops Ibalizumab, a monoclonal Antibody (mAb) and a member of HIV viral-entry inhibitor therapy. TaiMed Biologics Inc. was founded in 2007 and is based in Taipei, Taiwan.
TAIMED BIOLOGICS
Industry:
Biotechnology Medical Test And Measurement
Founded:
2007-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.taimedbiologics.com.tw
Total Employee:
11+
Status:
Active
Contact:
+886226558031
Total Funding:
22 M USD
Technology used in webpage:
Amazon Amazon Singapore Region
Similar Organizations
Cellective BioTherapy
Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency.
Torus Biosystems
Torus Biosystems is a biotech startup that delivers molecular diagnostics for infectious diseases.
United Biopharma
United Biopharma engages in integrated monoclonal antibody (mAb) drug development technology.
Current Employees Featured
Jack Chen Chief Financial Officer @ TaiMed Biologics
Chief Financial Officer
LanBo Chen Co-Founder @ TaiMed Biologics
Co-Founder
Ing-Wen Tsai Co-Founder @ TaiMed Biologics
Co-Founder
James Chang CEO @ TaiMed Biologics
CEO
David Ho Scientific Founder @ TaiMed Biologics
Scientific Founder
Chin-Ming Chang Chief Technology Officer @ TaiMed Biologics
Chief Technology Officer
Founder
Investors List
Taiwan Development Fund
Taiwan Development Fund investment in Series B - TaiMed Biologics
YFY Biotech Management Company
YFY Biotech Management Company investment in Series B - TaiMed Biologics
Official Site Inspections
http://www.taimedbiologics.com.tw
- Host name: ec2-52-77-87-190.ap-southeast-1.compute.amazonaws.com
- IP address: 52.77.87.190
- Location: Singapore Singapore
- Latitude: 1.2929
- Longitude: 103.8547
- Timezone: Asia/Singapore
- Postal: 18
